Bellevue Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $449K | Hold |
10,400
| – | – | 0.01% | 108 |
|
|
2025
Q1 | $360K | Hold |
10,400
| – | – | 0.01% | 124 |
|
|
2024
Q4 | $285K | Hold |
10,400
| – | – | 0.01% | 137 |
|
|
2024
Q3 | $265K | Sell |
10,400
-2,400
| -19% | -$61.1K | ﹤0.01% | 141 |
|
|
2024
Q2 | $324K | Hold |
12,800
| – | – | 0.01% | 137 |
|
|
2024
Q1 | $396K | Sell |
12,800
-20,500
| -62% | -$634K | 0.01% | 138 |
|
|
2023
Q4 | $1.34M | Sell |
33,300
-45,400
| -58% | -$1.83M | 0.02% | 116 |
|
|
2023
Q3 | $2.08M | Sell |
78,700
-18,200
| -19% | -$480K | 0.03% | 113 |
|
|
2023
Q2 | $1.67M | Buy |
96,900
+14,300
| +17% | +$246K | 0.02% | 118 |
|
|
2023
Q1 | $1.37M | Buy |
+82,600
| New | +$1.37M | 0.02% | 122 |
|